Alpha Tau Medical Ltd
DRTS · TASE · ILA
ILA 3,950.00
−87.00 −2.16%todayNot financial advice.
- Open
- 4,037.00
- Day range
- 3,885.00 - 4,117.00
- 52-week range
- 3,885.00 - 4,977.00
- Volume
- 13.14K
- Market cap
- 1.14B
- P/E ratio
- —
- EPS
- -1.04
- Dividend yield
- 0.00%
- Beta
- 0.53
Performance
W
−8.42%
1M
−12.61%
3M
−10.23%
6M
−10.23%
YTD
−10.23%
Y
−10.23%
5Y
−10.23%
All
−10.23%
In the news
Oct 19
FDA Clears Alpha Tau Medical to Expand Brain Cancer Trial Enrollment
Alpha Tau Medical received FDA clearance to expand its U.S. REGAIN brain cancer trial to 20 patients and add new endpoints ahead of Nov. 13 data.
Company news
Oct 19
FDA Approves Alpha Tau to Double Brain Cancer Trial Size Ahead of Upcoming Data
The FDA approved Alpha Tau Medical to double enrollment in its brain cancer study to 20 patients ahead of new trial results coming in November.
Company news
Oct 19
FDA Approves Alpha Tau Medical to Expand REGAIN Brain Trial
Alpha Tau Medical received FDA approval to expand its REGAIN glioblastoma trial to 20 patients, adding new endpoints and an upcoming interim analysis.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/TASE-DRTS" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Alpha Tau Medical Ltd (DRTS) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/TASE-DRTS">DRTS stock price</a> by FreeTheAI Stocks</p>